Prestige Consumer Healthcare Inc. (PBH): Revenue
$1.09B
Year ended 2026-03-31
$1.10B
Trailing 12 months to 2026-06-30
-1.2%
3-year compound annual growth
+2.9%
5-year compound annual growth
+3.0%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $1.09B | -4.3% | 2026-05-14, From 2025-04-01 |
| 2025-03-31 | $1.14B | +1.1% | 2026-05-14, From 2024-04-01 |
| 2024-03-31 | $1.13B | -0.2% | 2026-05-14, From 2023-04-01 |
| 2023-03-31 | $1.13B | +3.8% | 2025-05-09, From 2022-04-01 |
| 2022-03-31 | $1.09B | +15.2% | 2024-05-15, From 2021-04-01 |
| 2021-03-31 | $943.37M | -2.0% | 2023-05-05, From 2020-04-01 |
| 2020-03-31 | $963.01M | -1.3% | 2022-05-06, From 2019-04-01 |
| 2019-03-31 | $975.78M | -6.3% | 2021-05-07, From 2018-04-01 |
| 2018-03-31 | $1.04B | +18.0% | 2020-05-08, From 2017-04-01 |
| 2017-03-31 | $882.06M | +9.4% | 2019-05-13, From 2016-04-01 |
| 2016-03-31 | $806.25M | +13.0% | 2018-05-10, From 2015-04-01 |
| 2015-03-31 | $713.46M | +19.8% | 2015-05-14, From 2014-04-01 |
| 2014-03-31 | $595.64M | -3.4% | 2015-05-14, From 2013-04-01 |
| 2013-03-31 | $616.91M | +39.9% | 2015-05-14, From 2012-04-01 |
| 2012-03-31 | $441.08M | +31.1% | 2014-05-19, From 2011-04-01 |
| 2011-03-31 | $336.51M | +15.0% | 2013-05-17, From 2010-04-01 |
| 2010-03-31 | $292.60M | n/a | 2012-05-18, From 2009-04-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.09B | -4.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.07B | +11.9% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $958.40M | +432.1% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.24B | +4.3% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $943.71M | +33.8% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $883.37M | +43.8% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $868.45M | +21.5% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $829.45M | n/m |
| Alkermes plc. (ALKS) | 2025-12-31 | $1.48B | -5.2% |
Compare PBH, ACAD, MDGL, INDV side by side · Screen every company in Pharmaceutical Preparations ↗